Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for JMS Co., Ltd. (7702:JPX), powered by AI.
JMS Co., Ltd. is currently trading at ¥444. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for JMS Co., Ltd. on Alpha Lenz.
JMS Co., Ltd.'s P/E ratio is 122.2.
“JMS Co., Ltd. trades at a P/E of 122.2 (premium valuation) with modest ROE of 0.2%.”
Ask for details →JMS Co., Ltd. is a prominent player in the healthcare sector, specializing in the development, manufacturing, and distribution of medical devices and equipment. Their product range encompasses a variety of essential medical tools, such as blood circuit sets for hemodialysis, infusion pumps, and catheters, used extensively in hospitals and clinics globally. Serving a critical role in the medical industry, JMS Co., Ltd. ensures that healthcare providers across various segments, from nephrology to general surgery, have access to reliable and high-quality equipment. Headquartered in Japan, the company emphasizes innovation and quality assurance, setting industry standards through advanced research and development initiatives. JMS Co., Ltd. is integral to the efficient operation of healthcare facilities, directly impacting patient care and treatment outcomes. Its reliability and commitment to excellence underpin its reputation as a trusted partner in the medical community worldwide.
“JMS Co., Ltd. trades at a P/E of 122.2 (premium valuation) with modest ROE of 0.2%.”
Ask for details →JMS Co., Ltd. (ticker: 7702) is a company listed on JPX in the Healthcare sector (Medical Instruments & Supplies). It has approximately 5,469 employees. Market cap is $10.9B.
The current price is 444 with a P/E ratio of 122.21x and P/B of 0.27x.
ROE is 0.22% and operating margin is 1.25%. Annual revenue is $69.7B.